AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34754306 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load tasks
Number of subjects: 40
Study 34754306 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load tasks
Number of subjects: 40
Study 34754306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive load increase
Number of subjects: 40
Study 33168104 — intervention group
Group type: COMPARATOR
Intervention: 15 days before lockdown
Number of subjects: 27
Study 33168104 — intervention group
Group type: COMPARATOR
Intervention: 15 days during lockdown
Number of subjects: 27
Study 33168104 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 days after lockdown
Number of subjects: 27
Study 35559243 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of ziprasidone (60–80 mg/d) in combination with sertraline
Number of subjects: 62
Study 35559243 — intervention group
Group type: COMPARATOR
Intervention: Usual dose of ziprasidone (120–160 mg/d) monotherapy
Number of subjects: 62
Study 33041018 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-Education (n = 11)
Number of subjects: 32
Study 33041018 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Training (n = 11)
Number of subjects: 32
Study 33041018 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 32
Study 33785385 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 40
Study 33785385 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 35322843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry (9 g powder solubilized in water equivalent to 100 g of fresh cranberries, 525 mg total (poly)phenols)
Number of subjects: 45
Study 35322843 — intervention group
Group type: COMPARATOR
Intervention: Control (9 g powder, no (poly)phenols)
Number of subjects: 45
Study 34567223 — intervention group
Group type: EXPERIMENTAL
Intervention: Peppermint essential oil (3 drops inhaled for 7 nights)
Number of subjects: 105
Study 34567223 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essential oil (3 drops inhaled for 7 nights)
Number of subjects: 105
Study 34567223 — intervention group
Group type: COMPARATOR
Intervention: Control (3 drops of aromatic placebo inhaled for 7 nights)
Number of subjects: 105
Study 34644472 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-culture-derived quadrivalent inactivated influenza vaccine (IIV4c)
Number of subjects: 4514
Study 34644472 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal ACWY vaccine (control)
Number of subjects: 4514
Study 34644472 — intervention group
Group type: EXPERIMENTAL
Intervention: IIV4c
Number of subjects: 4514
Study 32675750 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 948
Study 32675750 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 948
Study 34983147 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding immediately before heel lance (group 1)
Number of subjects: 91
Study 34983147 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding one hour before heel lance (group 2)
Number of subjects: 91
Study 34983147 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding two hours before heel lance (group 3)
Number of subjects: 91
Study 34131001 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover veliparib monotherapy (300-400 mg twice daily continuous)
Number of subjects: 513
Study 34131001 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover veliparib monotherapy
Number of subjects: 513
Study 35366806 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use bronchoscopes (SUB, Ambu aScope)
Number of subjects: 46
Study 35366806 — intervention group
Group type: COMPARATOR
Intervention: Reusable bronchoscopes (CONV, Olympus BF-P60)
Number of subjects: 46
Study 35366806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analysis for single-use bronchoscopes (SUB)
Number of subjects: 46
Study 35366806 — intervention group
Group type: COMPARATOR
Intervention: Cost analysis for reusable bronchoscopes (CONV)
Number of subjects: 46
Study 33754156 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate nicotine reduction (VLNC cigarettes)
Number of subjects: 1250
Study 33754156 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual nicotine reduction (VLNC cigarettes)
Number of subjects: 1250
Study 33754156 — intervention group
Group type: COMPARATOR
Intervention: Control condition (normal nicotine content cigarettes)
Number of subjects: 1250
Study 32157678 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually customized tapering plan at discharge combined with telephone counselling one week after discharge
Number of subjects: 110
Study 32157678 — intervention group
Group type: COMPARATOR
Intervention: No tapering plan or telephone counselling
Number of subjects: 110
Study 35248915 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaleidoscope
Number of subjects: 60
Study 35248915 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 32707905 — intervention group
Group type: EXPERIMENTAL
Intervention: High amylose noodles (45% amylose)
Number of subjects: 12
Study 32707905 — intervention group
Group type: COMPARATOR
Intervention: Low amylose noodles (15% amylose)
Number of subjects: 12
Study 35908869 — intervention group
Group type: COMPARATOR
Intervention: PCV13 (13-valent pneumococcal vaccine)
Number of subjects: 245
Study 34221185 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-gene signature (TENM1, FN1, APOD, F12, BTNL8)
Number of subjects: 0
Study 34221185 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on gene expression and clinical characteristics
Number of subjects: 0
Study 34221185 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score and distant metastasis (M)
Number of subjects: 0
Study 32702912 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity pelvic floor muscle training (PFMT) 5 times a week for 30 minutes per day for 12 weeks
Number of subjects: 0
Study 32702912 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity pelvic floor muscle training (PFMT) twice a week for 15 minutes per day for 12 weeks
Number of subjects: 0
Study 33492719 — intervention group
Group type: COMPARATOR
Intervention: Normal PT (≤12.7 s)
Number of subjects: 1524
Study 33492719 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely prolonged PT (≥17.3 s)
Number of subjects: 1524
Study 33492719 — intervention group
Group type: EXPERIMENTAL
Intervention: Slightly prolonged PT (12.8≤PT≤15.0 s)
Number of subjects: 1524
Study 33492719 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediately prolonged PT (15.1≤PT≤17.2 s)
Number of subjects: 1524
Study 34021097 — intervention group
Group type: EXPERIMENTAL
Intervention: LEA + EX (15 kcal·kg fat-free mass-1·day-1)
Number of subjects: 6
Study 34021097 — intervention group
Group type: EXPERIMENTAL
Intervention: LEA - EX (15 kcal·kg fat-free mass-1·day-1)
Number of subjects: 6
Study 34021097 — intervention group
Group type: COMPARATOR
Intervention: CON + EX
Number of subjects: 6
Study 34021097 — intervention group
Group type: COMPARATOR
Intervention: CON - EX
Number of subjects: 6
Study 33350994 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated energy dietary supplement (55 mg of caffeine)
Number of subjects: 0
Study 33350994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33645308 — intervention group
Group type: EXPERIMENTAL
Intervention: GP endorsement on the letter accompanying the guaiac faecal occult blood testing kit
Number of subjects: 394842
Study 33645308 — intervention group
Group type: COMPARATOR
Intervention: Usual letter
Number of subjects: 394842
Study 32026506 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth educational intervention (4 sessions over 12 weeks)
Number of subjects: 92
Study 32026506 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 92
Study 34735004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cre8 EVO stents
Number of subjects: 1175
Study 34735004 — intervention group
Group type: COMPARATOR
Intervention: Resolute Onyx stents
Number of subjects: 1175
Study 34147867 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 minute step test (3MST1)
Number of subjects: 30
Study 34147867 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 minute step test (3MST2)
Number of subjects: 30
Study 34147867 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 minute step test (3MST)
Number of subjects: 30
Study 34661562 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart pill bottle reminder intervention for 4 weeks
Number of subjects: 61
Study 34661562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 61
Study 33595885 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer light and topical calcipotriol
Number of subjects: 26
Study 33595885 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcipotriol monotherapy
Number of subjects: 26
Study 33595885 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol-based regimen
Number of subjects: 26
Study 33595885 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol-based regimen
Number of subjects: 26
Study 32901654 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air circulation chamber (40.18 °C, 28.48% RH) for drying
Number of subjects: 100
Study 32901654 — intervention group
Group type: EXPERIMENTAL
Intervention: Silica gel desiccator (27.19 °C, 26.19% RH) for drying
Number of subjects: 100
Study 32901654 — intervention group
Group type: EXPERIMENTAL
Intervention: Refrigerator at 5 °C for storage
Number of subjects: 100
Study 32901654 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezer at -20 °C for storage
Number of subjects: 100
Study 32901654 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature (29 °C) with previous drying for storage
Number of subjects: 100
Study 32901654 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature (29 °C) without drying for storage
Number of subjects: 100
Study 36282407 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS); 18 sessions (twice a week for nine weeks)
Number of subjects: 56
Study 36282407 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 56
Study 34404588 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic traction + Distraction Osteogenesis
Number of subjects: 70
Study 34404588 — intervention group
Group type: COMPARATOR
Intervention: Distraction Osteogenesis
Number of subjects: 70
Study 35482651 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviorally based weight-loss treatments (BBWLTs)
Number of subjects: 191
Study 32558218 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital atherectomy (OA)
Number of subjects: 87
Study 32558218 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital atherectomy (OA) plus balloon angioplasty
Number of subjects: 87
Study 32558218 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents after OA
Number of subjects: 87
Study 33143547 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kgBW)
Number of subjects: 11
Study 33143547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 34001423 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of Planned Behavior
Number of subjects: 232
Study 32046537 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body hot pack thermal therapy (HPTT)
Number of subjects: 19
Study 32046537 — intervention group
Group type: COMPARATOR
Intervention: Waon therapy (WT)
Number of subjects: 19
Study 34626578 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein point-of-care testing (CRP POCT)
Number of subjects: 0
Study 34626578 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial training and training of new employees for CRP POCT
Number of subjects: 0
Study 34626578 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators for implementation of CRP POCT
Number of subjects: 0
Study 34626578 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall quality of CRP POCT implementation
Number of subjects: 0
Study 33021348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 926
Study 33021348 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 926
Study 35797653 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Facet Joint Denervation (EG)
Number of subjects: 40
Study 35797653 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Facet Joint Denervation (PG)
Number of subjects: 40
Study 34078097 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided CABG
Number of subjects: 100
Study 34078097 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided CABG
Number of subjects: 100
Study 34078097 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft failure or FFR<0.80
Number of subjects: 100
Study 34078097 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft failure or low FFR in deferred lesions
Number of subjects: 100
Study 34537184 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial appendage occlusion (LAAO) using Amplatzer Amulet or Watchman FLX with lifelong aspirin 75 mg daily
Number of subjects: 750
Study 34537184 — intervention group
Group type: COMPARATOR
Intervention: Novel oral anticoagulants (NOACs)
Number of subjects: 750
Study 32556718 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 502
Study 35879205 — intervention group
Group type: EXPERIMENTAL
Intervention: V-flap technique
Number of subjects: 20
Study 35879205 — intervention group
Group type: COMPARATOR
Intervention: Slit-arteriotomy technique
Number of subjects: 20
Study 33055462 — intervention group
Group type: EXPERIMENTAL
Intervention: TIV + PPSV23 (simultaneous inoculations of TIV and PPSV23)
Number of subjects: 40
Study 33055462 — intervention group
Group type: COMPARATOR
Intervention: TIV + Placebo (inoculations of TIV and placebo)
Number of subjects: 40
Study 33055462 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 32577745 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (starting with 50 μg, adjusted for weight and coronary heart disease)
Number of subjects: 230
Study 32577745 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mock titration)
Number of subjects: 230
Study 32577745 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (in participants with higher fatigability at baseline)
Number of subjects: 230
Study 32577745 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in participants with higher fatigability at baseline)
Number of subjects: 230
Study 35212924 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab+Pertuzumab (TP)
Number of subjects: 0
Study 35212924 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel+Trastuzumab+Pertuzumab (PTP)
Number of subjects: 0
Study 35212924 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel+Trastuzumab+Pertuzumab with macrophage depletion (PTP+C)
Number of subjects: 0
Study 35212924 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab+Pertuzumab with macrophage depletion (TP+C)
Number of subjects: 0
Study 35212924 — intervention group
Group type: COMPARATOR
Intervention: Control (Cremophor)
Number of subjects: 0
Study 35212924 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of TAM infiltrate in PTP, TP+C, and PTP+C
Number of subjects: 0
Study 35212924 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate depletion
Number of subjects: 0
Study 34525007 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 460
Study 34525007 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 460
Study 36071444 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-up arm: Intra-articular corticosteroid injection (IACI) in all affected joints for less severe oligoarthritis; IACI and methotrexate for polyarthritis or severe oligoarthritis.
Number of subjects: 0
Study 36071444 — intervention group
Group type: COMPARATOR
Intervention: Step-down arm: 6-month early combined treatment (methotrexate plus IACI for less severe oligoarthritis; methotrexate plus etanercept for severe oligoarthritis and polyarthritis).
Number of subjects: 0
Study 34058112 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 0
Study 34058112 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol
Number of subjects: 0
Study 35277771 — intervention group
Group type: EXPERIMENTAL
Intervention: eTEP repair
Number of subjects: 60
Study 35277771 — intervention group
Group type: COMPARATOR
Intervention: IPOM repair
Number of subjects: 60
Study 34250940 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) for 12 weeks
Number of subjects: 37
Study 34250940 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT)
Number of subjects: 37
Study 34714502 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive Parenting Program (7 sessions)
Number of subjects: 191
Study 34714502 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 191
Study 34309839 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) at 70 L min−1
Number of subjects: 40
Study 34309839 — intervention group
Group type: COMPARATOR
Intervention: Face mask with 7 cm H2O of PEEP
Number of subjects: 40
Study 32127550 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 68
Study 32127550 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologic Femi+ vaginal capsule
Number of subjects: 68
Study 32127550 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynophilus LP vaginal tablet
Number of subjects: 68
Study 32127550 — intervention group
Group type: COMPARATOR
Intervention: Behavioral counseling only (control)
Number of subjects: 68
Study 34312086 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 102
Study 34312086 — intervention group
Group type: EXPERIMENTAL
Intervention: Back Massage
Number of subjects: 102
Study 34312086 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 102
Study 32038104 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 86
Study 32038104 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 86
Study 35603644 — intervention group
Group type: EXPERIMENTAL
Intervention: COMPASS transitional care (COMPASS‐TC)
Number of subjects: 5882
Study 35603644 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5882
Study 33430957 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training intervention using Attentive Rehabilitation of Attention and Memory (ARAM) software, 45 minutes per session, twice a week for 10 sessions.
Number of subjects: 52
Study 33430957 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training intervention
Number of subjects: 52
Study 33430957 — intervention group
Group type: COMPARATOR
Intervention: Educational workshops (control group)
Number of subjects: 52
Study 33411550 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 27
Study 33411550 — intervention group
Group type: COMPARATOR
Intervention: Didactic educational counseling (DEC)
Number of subjects: 27
Study 34229709 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-sharing with community health workers for screening and pre-referral management of pre-eclampsia/eclampsia
Number of subjects: 0
Study 34229709 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers trained to identify basic danger signs of pregnancy
Number of subjects: 0
Study 34229709 — intervention group
Group type: COMPARATOR
Intervention: Healthcare facility preparedness
Number of subjects: 0
Study 34229709 — intervention group
Group type: COMPARATOR
Intervention: Access to ambulances for referrals
Number of subjects: 0
Study 34623488 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise program for 6 months
Number of subjects: 59
Study 34623488 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 59
Study 35346115 — intervention group
Group type: EXPERIMENTAL
Intervention: CALM program (integrated lifestyle program)
Number of subjects: 184
Study 35346115 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy (cognitive behavioural therapy)
Number of subjects: 184
Study 34008127 — intervention group
Group type: EXPERIMENTAL
Intervention: GMM-based tests for mediated effects
Number of subjects: 0
Study 34008127 — intervention group
Group type: COMPARATOR
Intervention: Traditional tests
Number of subjects: 0
Study 33371483 — intervention group
Group type: EXPERIMENTAL
Intervention: 2S-Hesperidin 500 mg/day
Number of subjects: 40
Study 33371483 — intervention group
Group type: COMPARATOR
Intervention: Placebo (microcellulose) 500 mg/day
Number of subjects: 40
Study 35150142 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐β‐hydroxybutyrate esters (KE) drink with 395 mgKE/kg
Number of subjects: 12
Study 35150142 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 12
Study 34279663 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c ≥ 8.0% in lowest tertile of glucose CV
Number of subjects: 6090
Study 34279663 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c ≥ 8.0% in middle tertile of glucose CV
Number of subjects: 6090
Study 34279663 — intervention group
Group type: COMPARATOR
Intervention: HbA1c 6.0%-6.9% in lowest and middle tertiles of glucose CV
Number of subjects: 6090
Study 34279663 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c in highest tertile of glucose CV
Number of subjects: 6090
Study 36198482 — intervention group
Group type: EXPERIMENTAL
Intervention: SEDLine monitoring during induction of anesthesia
Number of subjects: 0
Study 33755184 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep (overnight sleep with polysomnography)
Number of subjects: 98
Study 33755184 — intervention group
Group type: COMPARATOR
Intervention: Wake (daytime wake from 09:00 am to 21:00 pm)
Number of subjects: 98
Study 33755184 — intervention group
Group type: EXPERIMENTAL
Intervention: N3 sleep post-encoding
Number of subjects: 98
Study 35357314 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreliable source with protective message
Number of subjects: 307
Study 35357314 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreliable source without protective message
Number of subjects: 307
Study 35357314 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliable source with protective message
Number of subjects: 307